AAV5-mediated targeted decorin gene therapy: effective and safe for corneal fibrosis [abstract]

MOspace/Manakin Repository

Breadcrumbs Navigation

AAV5-mediated targeted decorin gene therapy: effective and safe for corneal fibrosis [abstract]

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/9146

[+] show full item record


Title: AAV5-mediated targeted decorin gene therapy: effective and safe for corneal fibrosis [abstract]
Author: Tandon, Ashish; Tovey, Jonathan; Gupta, Rangan, 1978-; Sharma, Ajay; Cowden, John W.; Schultz, Gregory
Keywords: blindness
fibrosis treatment
Date: 2010-11-11
Abstract: Corneal fibrosis is 3rd leading cause of global blindness according to WHO report. At present, no agents are proven to clinically reduce corneal fibrosis without causing significant side effects. It was hypothesized that decorin gene delivered into keratocytes prevents corneal fibrosis in the cornea in vivo by blocking transforming growth factor β (TGFb), which converts keratocyte to myofibroblasts and cause fibrosis.
URI: http://hdl.handle.net/10355/9146

This item appears in the following Collection(s)

[+] show full item record